These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 8605875
21. Activation of the JAK-STAT signal transduction pathway by oncostatin-M cultured human and mouse osteoblastic cells. Levy JB, Schindler C, Raz R, Levy DE, Baron R, Horowitz MC. Endocrinology; 1996 Apr; 137(4):1159-65. PubMed ID: 8625884 [Abstract] [Full Text] [Related]
22. Src directly tyrosine-phosphorylates STAT5 on its activation site and is involved in erythropoietin-induced signaling pathway. Okutani Y, Kitanaka A, Tanaka T, Kamano H, Ohnishi H, Kubota Y, Ishida T, Takahara J. Oncogene; 2001 Oct 04; 20(45):6643-50. PubMed ID: 11641791 [Abstract] [Full Text] [Related]
23. Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. Chrétien S, Varlet P, Verdier F, Gobert S, Cartron JP, Gisselbrecht S, Mayeux P, Lacombe C. EMBO J; 1996 Aug 15; 15(16):4174-81. PubMed ID: 8861946 [Abstract] [Full Text] [Related]
24. Signaling of type II oncostatin M receptor. Auguste P, Guillet C, Fourcin M, Olivier C, Veziers J, Pouplard-Barthelaix A, Gascan H. J Biol Chem; 1997 Jun 20; 272(25):15760-4. PubMed ID: 9188471 [Abstract] [Full Text] [Related]
25. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control. Sivko GS, Sanford DC, Dearth LD, Tang D, DeWille JW. J Cell Biochem; 2004 Nov 01; 93(4):844-56. PubMed ID: 15389878 [Abstract] [Full Text] [Related]
26. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway. Prigent-Tessier A, Barkai U, Tessier C, Cohen H, Gibori G. Endocrinology; 2001 Mar 01; 142(3):1242-50. PubMed ID: 11181541 [Abstract] [Full Text] [Related]
27. Thrombopoietin activates a STAT5-like factor in hematopoietic cells. Pallard C, Gouilleux F, Bénit L, Cocault L, Souyri M, Levy D, Groner B, Gisselbrecht S, Dusanter-Fourt I. EMBO J; 1995 Jun 15; 14(12):2847-56. PubMed ID: 7796811 [Abstract] [Full Text] [Related]
28. Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Tian SS, Tapley P, Sincich C, Stein RB, Rosen J, Lamb P. Blood; 1996 Dec 15; 88(12):4435-44. PubMed ID: 8977235 [Abstract] [Full Text] [Related]
30. Epo-induced hemoglobinization of SKT6 cells is mediated by minimal cytoplasmic domains of the Epo or prolactin receptors without modulation of GATA-1 or EKLF. Reese TT, Gregory RC, Sharlow ER, Pacifici RE, Crouse JA, Todokoro K, Wojchowski DM. Growth Factors; 1997 Dec 15; 14(2-3):161-76. PubMed ID: 9255607 [Abstract] [Full Text] [Related]
31. Erythropoietin can induce the expression of bcl-x(L) through Stat5 in erythropoietin-dependent progenitor cell lines. Silva M, Benito A, Sanz C, Prosper F, Ekhterae D, Nuñez G, Fernandez-Luna JL. J Biol Chem; 1999 Aug 06; 274(32):22165-9. PubMed ID: 10428780 [Abstract] [Full Text] [Related]
32. Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. Beadling C, Ng J, Babbage JW, Cantrell DA. EMBO J; 1996 Apr 15; 15(8):1902-13. PubMed ID: 8617237 [Abstract] [Full Text] [Related]
33. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Quelle FW, Wang D, Nosaka T, Thierfelder WE, Stravopodis D, Weinstein Y, Ihle JN. Mol Cell Biol; 1996 Apr 15; 16(4):1622-31. PubMed ID: 8657137 [Abstract] [Full Text] [Related]
34. STAT1 is involved in signal transduction in the EPO induced HEL cells. Chu J, Gui CY, Fan J, Tang XD, Qiao RL. Cell Res; 1998 Jun 15; 8(2):105-17. PubMed ID: 9669026 [Abstract] [Full Text] [Related]
35. Multiple tyrosine residues in the cytosolic domain of the erythropoietin receptor promote activation of STAT5. Klingmüller U, Bergelson S, Hsiao JG, Lodish HF. Proc Natl Acad Sci U S A; 1996 Aug 06; 93(16):8324-8. PubMed ID: 8710869 [Abstract] [Full Text] [Related]
37. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines. Lin JX, Leonard WJ. Oncogene; 2000 May 15; 19(21):2566-76. PubMed ID: 10851055 [Abstract] [Full Text] [Related]
38. Reconstitution of the functional mouse oncostatin M (OSM) receptor: molecular cloning of the mouse OSM receptor beta subunit. Tanaka M, Hara T, Copeland NG, Gilbert DJ, Jenkins NA, Miyajima A. Blood; 1999 Feb 01; 93(3):804-15. PubMed ID: 9920829 [Abstract] [Full Text] [Related]
39. Low doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cells. Ammarguellat F, Llovera M, Kelly PA, Goffin V. Biochem Biophys Res Commun; 2001 Jun 22; 284(4):1031-8. PubMed ID: 11409898 [Abstract] [Full Text] [Related]
40. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription. Berchtold S, Volarevic S, Moriggl R, Mercep M, Groner B. Mol Endocrinol; 1998 Apr 22; 12(4):556-67. PubMed ID: 9544991 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]